At the conclusion of this activity, the participant will be able to:

1.  Describe methods of quantifying stromal tumor infiltrating lymphocytes in breast biopsies and resection specimens

2. Understand the prognostic utility of tumor infiltrating lymphocytes in the breast

3. Discuss the implications of tumor infiltrating lymphocytes in immunotherapy

 

plate with fork and knife, books, microscope and test tubes
Sponsor(s)
Medicine: Pathology
Speaker(s)
Bryce Hatfield, MD, Surgical Pathology Fellow, Virginia Commonwealth University Health System
Audience
All ( Open to the public )